<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00575601</url>
  </required_header>
  <id_info>
    <org_study_id>850-39-4796</org_study_id>
    <nct_id>NCT00575601</nct_id>
  </id_info>
  <brief_title>Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients</brief_title>
  <official_title>Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients : A Prospective Randomized Double Blind Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether simvastatin is effective in the improvement
      of IVF-ICSI outcome in Pcos patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      simvastatin reduces cardiovascular risks by improving hypercholesterolemia, reducing vascular
      smooth muscle proliferation, ameliorating inflammation, limiting theca-interstitial
      proliferation &amp; decreasing steroidogenesis (production of progesterone &amp;
      testosterone).Polycystic ovary syndrome (pcos) is associated with increased cardiovascular
      risks and is characterized by ovarian theca-interstitial hyperplasia&amp; hyperandrogenism .This
      study will test the hypothesis that simvastatin improves biochemical parameters&amp; IVF-ICSI
      outcome in Pcos patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ivf-et outcomes</measure>
    <time_frame>14-20 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical parameters baseline and 8weeks Biochemical parameters</measure>
    <time_frame>baseline and 8weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SIMVASTATIN</intervention_name>
    <description>20 mg/day,po,for two months until the day of hCG injection placebo pills as like as simvastatin will be used</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pcos patients

          -  Age &lt;40 years

          -  FSH&lt;10 IU/L

        Exclusion Criteria:

          -  Endometriosis grade 3 &amp;4

          -  History of tubal surgery

          -  Hydrosalpinx

          -  History of mellitis diabetes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>batool hossein rashidi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Imam Khomeiny Hospital</name>
      <address>
        <city>Tehran</city>
        <zip>1419733141</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2007</study_first_submitted>
  <study_first_submitted_qc>December 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2007</study_first_posted>
  <last_update_submitted>June 30, 2009</last_update_submitted>
  <last_update_submitted_qc>June 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Akabr Fotouhi</name_title>
    <organization>Tehran University of Medical Sciences</organization>
  </responsible_party>
  <keyword>pco</keyword>
  <keyword>simvastatin</keyword>
  <keyword>ivf</keyword>
  <keyword>embryo transfer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

